Oxigene, Inc.
Company Information

701 Gateway Blvd Ste 210
South San Francisco, CA, 94080 United States
(650) 635-7000

Top 3 Competitors

Unlock more access to Hoover’s!

  • Build customized email lists 24/7, based on your best customer profile.
  • Learn more about the companies you want to sell to. Hoover’s has reports on 85+ million companies and 900 industries. 65,000 data points are updated each day.
  • Get real insight written by real people – exclusive research and reviews by our in-house Editorial staff.
  • We can deliver our data to your desktop, to Excel, direct to your CRM, into your custom app, or via mobile.

Call (866) 473-3932 today to get started with a FREE TRIAL!


Oxigene, Inc. Company Profile

OXiGENE is a biopharmaceutical company focused on vascular targeted therapy in oncology, which starves cancer to death. Its vascular targeted therapy include vascular disrupting agents (VDAs) and anti-angiogenic agents (AAs). VDAs selectively obstruct a tumor's blood supply without obstructing the blood supply to normal tissues, and treatment with our VDAs has been shown to lead to significant central tumor necrosis. OXiGENE believes that the treatment of cancer is significantly improved if VDAs and AAs are used together. The company's strategy is to identify and license compounds from academic research centers and then shepherd the compounds through clinical trials.